Open access · OA
via OpenAlex
EEG evidence of compensatory mechanisms in preclinical Alzheimer’s disease
Sinead Gaubert, Federico Raimondo, Marion Houot, Marie‐Constance Corsi, Lionel Naccache, Jacobo Diego Sitt, Bertrand Hermann, Delphine Oudiette, Geoffroy Pierre Gagliardi, Marie‐Odile Habert, Bruno Dubois, Fabrizio De Vico Fallani, Hovagim Bakardjian, Stéphane Epelbaum, Alzheimer’s Disease Neuroimaging Initiative
Brain · 2019 · ▲ 236 citations
Abstract
Early biomarkers are needed to identify individuals at high risk of preclinical Alzheimer's disease and to better understand the pathophysiological processes of disease progression. Preclinical Alzheimer's disease EEG changes would be non-invasive and cheap screening tools and could also help to predict future progression to clinical Alzheimer's disease. However, the impact of amyloid-β deposition and neurodegeneration on EEG biomarkers needs to be elucidated. We included participants from the INSIGHT-preAD cohort, which is an ongoing single-centre multimodal observational study that was designed to identify risk factors and markers of progression to clinical Alzheimer's disease in 318 cognitively normal individuals aged 70-85 years with a subjective memory complaint. We divided the subjects into four groups, according to their amyloid status (based on 18F-florbetapir PET) and neurodegeneration status (evidenced by 18F-fluorodeoxyglucose PET brain metabolism in Alzheimer's disease signature regions). The first group was amyloid-positive and neurodegeneration-positive, which corresponds to stage 2 of preclinical Alzheimer's disease. The second group was amyloid-positive and neurodegeneration-negative, which corresponds to stage 1 of preclinical Alzheimer's disease. The third group was amyloid-negative and neurodegeneration-positive, which corresponds to 'suspected non-Alzheimer's pathophysiology'. The last group was the control group, defined by amyloid-negative and neurodegeneration-negative subjects. We analysed 314 baseline 256-channel high-density eyes closed 1-min resting state EEG recordings. EEG biomarkers included spectral measures, algorithmic complexity and functional connectivity assessed with a novel information-theoretic measure, weighted symbolic mutual information. The most prominent effects of neurodegeneration on EEG metrics were localized in frontocentral regions with an increase in high frequency oscillations (higher beta and gamma power) and a decrease in low frequency oscillations (lower delta power), higher spectral entropy, higher complexity and increased functional connectivity measured by weighted symbolic mutual information in theta band. Neurodegeneration was associated with a widespread increase of median spectral frequency. We found a non-linear relationship between amyloid burden and EEG metrics in neurodegeneration-positive subjects, either following a U-shape curve for delta power or an inverted U-shape curve for the other metrics, meaning that EEG patterns are modulated differently depending on the degree of amyloid burden. This finding suggests initial compensatory mechanisms that are overwhelmed for the highest amyloid load. Together, these results indicate that EEG metrics are useful biomarkers for the preclinical stage of Alzheimer's disease.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1093/brain/awz150
- Canonical
- link ↗
- Fetched
- 2026-10-29 MST
Cite this
APA
Gaubert, S., Raimondo, F., Houot, M., Corsi, M., Naccache, L., Sitt, J.D., Hermann, B., Oudiette, D., Gagliardi, G.P., Habert, M., Dubois, B., Fallani, F.D.V., Bakardjian, H., Epelbaum, S., & Initiative, A.D.N. (2019). EEG evidence of compensatory mechanisms in preclinical Alzheimer’s disease. <em>Brain</em>. https://doi.org/10.1093/brain/awz150
Vancouver
Gaubert S, Raimondo F, Houot M, Corsi M, Naccache L, Sitt JD, et al. EEG evidence of compensatory mechanisms in preclinical Alzheimer’s disease. Brain. 2019. doi:10.1093/brain/awz150.
BibTeX
@article{sinead2019EEGevi,
title = {EEG evidence of compensatory mechanisms in preclinical Alzheimer’s disease},
author = {Sinead Gaubert and Federico Raimondo and Marion Houot and Marie‐Constance Corsi and Lionel Naccache and Jacobo Diego Sitt and Bertrand Hermann and Delphine Oudiette and Geoffroy Pierre Gagliardi and Marie‐Odile Habert and Bruno Dubois and Fabrizio De Vico Fallani and Hovagim Bakardjian and Stéphane Epelbaum and Alzheimer’s Disease Neuroimaging Initiative},
journal = {Brain},
year = {2019},
doi = {10.1093/brain/awz150},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Manchester Metropolitan University 2026
Open access · US-GOV
Surveying the Dietary Intake, Physical Activity Patterns, Muscle Strength and Morphology of Adults With Inclusion Body Myositis
Acta Physiologica 2015
Citation only
Caloric restriction reduces age‐related but not all‐cause mortality
Frontiers in Aging Neuroscience 2021
Open access · CC-BY
A Meta-Analysis of Brain DNA Methylation Across Sex, Age, and Alzheimer's Disease Points for Accelerated Epigenetic Aging in Neurodegeneration
Frontiers in Neuroscience 2023
Open access · CC-BY
Implication of tau propagation on neurodegeneration in Alzheimer’s disease
Aging and Disease 2025
Open access · CC-BY
Type 2 Diabetes Mellitus: A Metabolic Model of Accelerated Aging - Multi-Organ Mechanisms and Intervention Approaches
Alzheimer s & Dementia 2022
Preprint · CC0